Unlike earlier GLP-1 receptor agonists like semaglutide (Ozempic/Wegovy) that target a single hormone pathway, or tirzepatide (Mounjaro/Zepbound) that targets two, retatrutide activates three distinct metabolic receptors : GIP, GLP-1, and glucagon
However such evidence is not forthcoming
With the brand new JDC Burst 1, GLP continues its success story with a significantly more powerful strobe/wash hybrid Inspired by the innovative technology of the new JDC2 IP, and building on the success of the legendary JDC1, the JDC Burst 1 delivers an impressive blend of power, colour intensity, and flexibility
Standard / Gradual Approach A representative reference vial is compounded at roughly methionine 25 mg/mL + inositol 50 mg/mL + choline 50 mg/mL (125 mg/mL combined MIC) with ~1000 mcg/mL B12 , though ratios such as 25/25/25 are equally common [1]